BDNF and myeloid sarcoma: Interestingly, we showed that the severity and progression of multiple sclerosis (MS) were not influenced by the CSF levels of miR-142-3p in patients with BDNF Met66-allele background, whereas Val/Val patients with high levels of miR-142-3p exhibited a more severe phenotype.